Literature DB >> 7777187

Chronically administered 3-nitropropionic acid induces striatal lesions attributed to dysfunction of the blood-brain barrier.

H Nishino1, Y Shimano, M Kumazaki, T Sakurai.   

Abstract

3-Nitropropionic acid (3-NPA), an irreversible inhibitor of succinate dehydrogenase, was administered to rats and the characteristics of the neuronal damage were investigated. Injections of 3-NPA (15 mg/kg s.c.) every 2 or 3 days for 1-2 weeks induced a mild neuronal loss and neutrophil invasions in the striatum (STR). The same administration for 4 weeks induced specific symmetric lesions in the lateral STR although the size was variable in each animal. Inside the lesions, strong neutrophil invasions and a strong immunoreaction for IgG, C3 as well as complement factor C3b/C4b receptor (C3b/C4br) were detected. Lesioned sites lost the immunoreaction for GFAP while the marginal areas contained abundant GFAP-labeled astrocytes around the vessels. In intoxicated animals, there was a weak but stout immunoreaction for IgG and C3b/C4br localizing around vessels in the STR even when there were no lesions or neuronal loss. The data suggest that the blood-brain barrier dysfunction is responsible for the specific vulnerability of the STR for the toxin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7777187     DOI: 10.1016/0304-3940(95)11311-j

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  Animal models for glutaryl-CoA dehydrogenase deficiency.

Authors:  D M Koeller; S Sauer; M Wajner; C F de Mello; S I Goodman; M Woontner; C Mühlhausen; J G Okun; S Kölker
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

2.  Berberine Ameliorate Haloperidol and 3-Nitropropionic Acid-Induced Neurotoxicity in Rats.

Authors:  Abdul Kadir; Jasdeep Singh; Vikrant Rahi; Puneet Kumar
Journal:  Neurochem Res       Date:  2022-07-25       Impact factor: 4.414

3.  Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease.

Authors:  D S Reynolds; R J Carter; A J Morton
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

Review 4.  Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015-2020.

Authors:  Niklas Huntemann; Leoni Rolfes; Marc Pawlitzki; Tobias Ruck; Steffen Pfeuffer; Heinz Wiendl; Sven G Meuth
Journal:  Drugs       Date:  2021-06-04       Impact factor: 9.546

5.  Basal Mitophagy Occurs Independently of PINK1 in Mouse Tissues of High Metabolic Demand.

Authors:  Thomas G McWilliams; Alan R Prescott; Lambert Montava-Garriga; Graeme Ball; François Singh; Erica Barini; Miratul M K Muqit; Simon P Brooks; Ian G Ganley
Journal:  Cell Metab       Date:  2018-01-11       Impact factor: 27.287

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.